2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$186.02+$4.46 (+2.46%)
Price as of Jun 23, 2026 11:58 AM EDT- $8.7BMarket Cap
- 23.19%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$186.02+$4.46 (+2.46%)
Annual
Quarterly
12/27/2025 | 12/28/2024 | 12/30/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.3B -19.75% | 4.0B -1.92% | 4.1B +3.86% | 4.0B +12.31% | |
Cost of Revenue | 2.3B -57.42% | 5.4B +106.95% | 2.6B +4.51% | 2.5B +13.96% | |
Gross Profit | 935.3M +167.47% | -1.4B -192.27% | 1.5B +2.73% | 1.5B +9.59% | |
Sales and Marketing Expense | 743.1M -1.06% | 751.0M +0.42% | 747.9M +12.44% | 665.1M +7.29% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 403.3M +11.49% | 361.7M +15.16% | 314.1M +3.37% | 303.9M +14.43% | |
Total Operating Expenses | 2.3B -57.42% | 5.4B +106.95% | 2.6B +4.51% | 2.5B +13.96% | |
Operating Profit | 25.2M -88.93% | 227.3M -63.17% | 617.3M -5.18% | 651.0M +10.36% | |
Interest Income | 4.9M -42.39% | 8.6M +65.03% | 5.2M +566.15% | 780,000 +19.63% | |
Interest Expense | N/A N/A | N/A N/A | -136.7M +130.57% | -59.3M -19.78% | |
Interest Income and Expense and Net | 4.9M -42.39% | 8.6M +106.52% | -131.5M +124.77% | -58.5M -20.13% | |
Total Nonoperating Income and Expense | -22.6M +36.66% | -16.5M -117.29% | 95.5M +213.00% | 30.5M +185.04% | |
Income before Taxes | -99.5M -206.86% | 93.1M -83.98% | 581.3M -6.69% | 623.0M +29.60% | |
Income Taxes | 42.7M -37.10% | 67.8M -32.79% | 100.9M -22.60% | 130.4M +59.25% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -144.3M -750.08% | 22.2M -95.32% | 474.6M -2.39% | 486.2M +24.36% | |
Net Income from Continuing Operations Applicable to Common | -144.3M -1,501.75% | 10.3M -97.83% | 474.6M -23.81% | 623.0M +29.60% | |
Basic EPS and Net Income | -2.91 -1,555.00% | 0.20 -97.84% | 9.27 -3.13% | 9.57 +23.17% | |
Diluted EPS and Net Income | -2.91 -1,555.00% | 0.20 -97.83% | 9.22 -2.74% | 9.48 +24.74% | |
Basic Weighted Average Shares | 49.6M -3.53% | 51.4M +0.30% | 51.2M +0.82% | 50.8M +1.03% | |
Diluted Weighted Average Shares | 49.6M -4.00% | 51.6M +0.34% | 51.5M +0.29% | 51.3M -0.24% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 213.8M +9.85% | 194.6M -29.69% | 276.8M +18.32% | 233.9M -3.03% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 213.8M +9.85% | 194.6M -29.69% | 276.8M +18.32% | 233.9M -3.45% | |
Total Current Assets | 1.4B +3.13% | 1.4B -12.78% | 1.6B +11.79% | 1.4B +12.95% | |
Accumulated Depreciation | 1.5B +5.75% | 1.5B +8.90% | 1.3B +15.00% | 1.2B +5.27% | |
Property and Plant and Equipment and Net | 1.7B +3.19% | 1.6B -2.18% | 1.6B +11.88% | 1.5B +13.52% | |
Total Long-Term Assets | 293.2M +5.37% | 278.2M -10.07% | 309.4M +108.65% | 148.3M -57.98% | |
Total Assets | 7.1B -5.22% | 7.5B -8.13% | 8.2B +7.79% | 7.6B +8.24% | |
Income Taxes Payable | 95.2M -10.99% | 107.0M -44.10% | 191.3M -11.24% | 215.6M -10.07% | |
Total Short-Term Debt | 3.6M +15.43% | 3.1M -64.72% | 8.7M +74.00% | 5.0M +79.75% | |
Total Current Liabilities | 1.1B +12.70% | 994.1M -5.78% | 1.1B -3.34% | 1.1B +5.65% | |
Total Long-Term Debt | 2.1B -4.64% | 2.2B -15.37% | 2.6B -2.23% | 2.7B +1.65% | |
Total Long-Term Liabilities | 138.3M -29.15% | 195.2M -12.54% | 223.2M +27.67% | 174.8M -28.02% | |
Total Liabilities | 3.9B -2.39% | 4.0B -11.37% | 4.5B -0.94% | 4.6B +3.32% | |
Retained Earnings | 1.4B -23.37% | 1.8B -3.98% | 1.9B +31.71% | 1.4B +46.10% | |
Total Stockholders Equity | 3.2B -8.58% | 3.5B -3.76% | 3.6B +20.85% | 3.0B +17.42% | |
Total Shares Outstanding | 49.2M -3.76% | 51.1M -0.38% | 51.3M +0.77% | 50.9M +0.92% | |
Cash Flow | |||||
Cash from Operating Activities | 737.6M +0.42% | 734.6M +7.41% | 683.9M +10.37% | 619.6M -18.55% | |
Capital Expenditures | 219.2M -5.93% | 233.0M -26.86% | 318.5M -1.91% | 324.7M +41.95% | |
Cash from Investing Activities | -209.3M -14.59% | -245.1M -56.48% | -563.2M -7.36% | -607.9M -57.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -536.7M -2.58% | -550.9M +544.20% | -85.5M +101.71% | -42.4M -106.30% | |
Financials Ratio | |||||
Gross Margin | 28.78% +184.07% | -34.23% -194.08% | 36.39% -1.09% | 36.79% -2.42% | |
Operating Margin | 0.77% -86.21% | 5.61% -62.45% | 14.95% -8.70% | 16.37% -1.74% | |
Return on Assets | -1.97% -797.10% | 0.28% -95.30% | 6.01% -9.62% | 6.65% +6.40% | |
Return on Equity | -4.36% -792.51% | 0.63% -95.64% | 14.44% -18.16% | 17.65% +4.92% | |
Revenue Growth | -19.75% +926.90% | -1.92% -149.87% | 3.86% -68.68% | 12.31% -41.58% | |
Current Ratio | 1.29 -8.49% | 1.41 -7.43% | 1.52 +15.66% | 1.32 +6.90% | |
Cash Ratio | 0.19 -2.55% | 0.20 -25.35% | 0.26 +22.40% | 0.21 -8.22% | |
Debt-to-Equity Ratio | 0.68 +4.34% | 0.65 -12.23% | 0.74 -18.98% | 0.91 -13.36% | |
Debt-to-Assets Ratio | 0.30 +0.64% | 0.30 -8.05% | 0.32 -9.16% | 0.36 -6.01% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow